Characterization of a human glutathione S-transferase μ cluster containing a duplicated GSTM1 gene that causes ultrarapid enzyme activity

被引:94
作者
McLellan, RA
Oscarson, M
Alexandrie, AK
Seidegård, J
Evans, DAP
Rannug, A
Ingelman-Sundberg, M
机构
[1] Karolinska Inst, Inst Environm Med, Div Mol Toxicol, S-17177 Stockholm, Sweden
[2] Karolinska Inst, Inst Environm Med, Unit Genet Toxicol, S-17177 Stockholm, Sweden
[3] Natl Inst Working Life, S-17184 Solna, Sweden
[4] Wallenberg Inst & Labs, S-22100 Lund, Sweden
[5] Astro Draco AB, S-22100 Lund, Sweden
[6] C 123 Riyadh Armed Forces Hosp, Riyadh 11159, Saudi Arabia
关键词
D O I
10.1124/mol.52.6.958
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The mu class glutathione S-transferase gene GSTM1 is polymorphic in humans, with approximately half of the Caucasian population being homozygous deleted for this gene. GSTM1 enzyme deficiency has been suggested to predispose people to lung and bladder cancer, Some people in a Saudi Arabian population, however, have been described previously with ultrarapid GSTM1 enzyme activity. Here we have evaluated the molecular genetic basis for this observation. Genomic DNA from two Saudi Arabian subjects exhibiting ultrarapid enzyme activity and from 13 Swedish subjects having null, one, or two GSTM1 genes were subjected to restriction fragment length polymorphism analysis using the restriction enzymes EcoRI, EcoRV, and HindIII and combinations thereof, Hybridization was carried out using a full-length GSTM1 cDNA or the 5' and 3' parts of the cDNA. The restriction mapping data revealed the presence of a GST mu cluster with two GSTM1 genes in tandem situated between the GSTM2 and GSTM5 genes. A quantitative multiplex polymerase chain reaction method? which simultaneously amplified a fragment of the GSTM1 gene and the beta-globin gene, was developed, and the genomic GSTM1 copy number was determined from the GSTM1/beta-globin ratio. This method clearly separated GSTM1 +/- subjects (ratios between 0.4 and 0.7) from GSTM1 +/+ subjects (ratios between 0.8 and 1.2). The two Saudi Arabians with ultrarapid GSTM1 activities had ratios of approximately 1.5, indicating that they carried three GSTM1 genes. These results demonstrate the existence of a novel mu class GST cluster containing a duplicated active GSTM1 gene causing ultrarapid enzyme activity.
引用
收藏
页码:958 / 965
页数:8
相关论文
共 40 条
[1]  
Aklillu E, 1996, J PHARMACOL EXP THER, V278, P441
[2]   GENETIC SUSCEPTIBILITY TO LUNG-CANCER WITH SPECIAL EMPHASIS ON CYP1A1 AND GSTM1 - A STUDY ON HOST FACTORS IN RELATION TO AGE AT ONSET, GENDER AND HISTOLOGICAL CANCER TYPES [J].
ALEXANDRIE, AK ;
SUNDBERG, MI ;
SEIDEGARD, J ;
TORNLING, G ;
RANNUG, A .
CARCINOGENESIS, 1994, 15 (09) :1785-1790
[3]   GENITAL HUMAN PAPILLOMAVIRUS INFECTION IN FEMALE UNIVERSITY-STUDENTS AS DETERMINED BY A PCR-BASED METHOD [J].
BAUER, HM ;
TING, Y ;
GREER, CE ;
CHAMBERS, JC ;
TASHIRO, CJ ;
CHIMERA, J ;
REINGOLD, A ;
MANOS, MM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 265 (04) :472-477
[4]   GENETIC RISK AND CARCINOGEN EXPOSURE - A COMMON INHERITED DEFECT OF THE CARCINOGEN-METABOLISM GENE GLUTATHIONE-S-TRANSFERASE M1 (GSTM1) THAT INCREASES SUSCEPTIBILITY TO BLADDER-CANCER [J].
BELL, DA ;
TAYLOR, JA ;
PAULSON, DF ;
ROBERTSON, CN ;
MOHLER, JL ;
LUCIER, GW .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (14) :1159-1164
[5]   MOLECULAR-BASIS FOR RATIONAL MEGAPRESCRIBING IN ULTRARAPID HYDROXYLATORS OF DEBRISOQUINE [J].
BERTILSSON, L ;
DAHL, ML ;
SJOQVIST, F ;
ABERGWISTEDT, A ;
HUMBLE, M ;
JOHANSSON, I ;
LUNDQVIST, E ;
INGELMANSUNDBERG, M .
LANCET, 1993, 341 (8836) :63-63
[6]   GENETIC-HETEROGENEITY OF THE HUMAN GLUTATHIONE TRANSFERASES - A COMPLEX OF GENE FAMILIES [J].
BOARD, P ;
COGGAN, M ;
JOHNSTON, P ;
ROSS, V ;
SUZUKI, T ;
WEBB, G .
PHARMACOLOGY & THERAPEUTICS, 1990, 48 (03) :357-369
[7]  
BOARD PG, 1981, AM J HUM GENET, V33, P36
[8]   CORRELATION BETWEEN TRANS-STILBENE OXIDE-GLUTATHIONE CONJUGATION ACTIVITY AND THE DELETION MUTATION IN THE GLUTATHIONE-S-TRANSFERASE CLASS MU GENE DETECTED BY POLYMERASE CHAIN-REACTION [J].
BROCKMOLLER, J ;
GROSS, D ;
KERB, R ;
DRAKOULIS, N ;
ROOTS, I .
BIOCHEMICAL PHARMACOLOGY, 1992, 43 (03) :647-650
[9]  
BROCKMOLLER J, 1993, CANCER RES, V53, P1004
[10]  
BROCKMOLLER J, 1994, CANCER RES, V54, P4103